Home Applications 218585 Application 218585
Type NDA
Sponsor LENZ THERAP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VIZZ ACECLIDINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC EQ 1.44% BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218585-001 VIZZ ACECLIDINE HYDROCHLORIDE EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 N218585-001 12653779 2035-06-18 U-3741 2026-07-13 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 N218585-001 12533347 2039-10-08 U-3741 2026-02-17 N218585-001 12414942 2044-03-15 U-3741 2025-10-01
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218585-001 NCE 2030-07-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 6a471c1ec25d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 VIZZ EQ 1.44% BASE SOLUTION/DROPS / OPHTHALMIC RLD, RS 2025-07-31 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 12653779 2035-06-18 U-3741 2026-07-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 12533347 2039-10-08 U-3741 2026-02-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N218585-001 12414942 2044-03-15 U-3741 2025-10-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 12653779 2035-06-18 U-3741 2026-07-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 12533347 2039-10-08 U-3741 2026-02-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N218585-001 12414942 2044-03-15 U-3741 2025-10-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218585-001 12414942 2044-03-15 U-3741 2025-10-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 12414942 2044-03-15 U-3741 2025-10-01 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 10052313 2034-03-24 U-3741 Drug product 2025-08-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 11179328 2034-03-24 U-3741 2025-08-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 9844537 2034-03-24 U-3741 Drug product 2025-08-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 12128036 2039-10-08 U-3741 2025-08-22 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 12533347 2039-10-08 U-3741 2026-02-17 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 12414942 2044-03-15 U-3741 2025-10-01 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-09-14 22:38:34 2026-08 N218585-001 NCE 2030-07-31 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218585-001 NCE 2030-07-31 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218585-001 NCE 2030-07-31 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218585-001 NCE 2030-07-31 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218585-001 NCE 2030-07-31 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VIZZ ACECLIDINE LENZ Therapeutics, Inc. 7aed8024-ad30-44d6-8f3b-63338ad3ce52 2026-01-14 Warnings, Adverse reactions Exact identifier application applno (NDA): 218585 application number: NDA218585
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents# Document, Submission type, Date table Document Submission type Date 83167 ORIG 2025-08-22 83026 ORIG 2025-08-01 83022 ORIG 2025-08-01